Guo Guangchang: Let’s Invest in Shanghai and Share the Future!

Release time:2024-05-26 Content sourced from: Page View:


On 23 May, the “Invest in Shanghai, Share the Future” Overseas Promotion Campaign (New York, U.S.) was successfully held in New York. Shanghai Mayor Gong Zheng delivered a keynote speech at the promotion event, said, “Shanghai is speeding up the process of building itself into an international center of economy, finance, trade, shipping, and technological innovation, fostering new productivity boosters, and forging ahead with high-level reform and opening-up”. Craig Allen, president of the U.S.-China Business Council (USCBC), Stephen Orlins, president of the National Committee of U.S.-China Relations, and Huang Ping, Chinese Consul General in New York delivered speeches at the promotion event, which was attended by around 150 attendees, including high-ranking officials, bankers, entrepreneurs from Shanghai, and scores of business leaders of international companies from the U.S.


As a representative of Shanghai enterprises, Guo Guangchang, Chairman of Fosun International gave a speech at the promotion event


As a representative of Chinese enterprises, Guo Guangchang, Chairman of Fosun International gave a speech at the promotion event. He said, “Fosun was founded in 1992 in Shanghai. In the course of development, we have always firmly taken Shanghai as the core city for Fosun’s development. We have remained rooted in Shanghai, rooted in China, while serving the world.”


Speaking of Fosun’s strategy, Guo Guangchang stated that Fosun has always clearly identified innovation and globalization as the two core growth drivers. Fosun has regarded the U.S. as one of the key countries for its global development and promoted the establishment of overseas enterprises in Shanghai through joint ventures, achieving win-win cooperation. Last October, the first domestically-produced Da Vinci Xi Surgical System was officially unveiled at Intuitive Fosun Headquarters and Industrialization Base in Pudong, Shanghai, marking the official realization of the localization of the world-leading Da Vinci Surgical System. Yi Kai Da (ejilunsai injection), a CAR-T cell therapy product jointly developed by Fosun Pharma and the American company Kite Pharma, has commenced production in Pudong, Shanghai. Since its approval for marketing by the National Medical Products Administration (NMPA) in June 2021, Yi Kai Da has successfully been used to treat more than 700 lymphoma patients.


On 6 November 2023, the domestically-produced Da Vinci Xi Surgical System was officially launched, realizing the localization of the Da Vinci Surgical System


Since its approval for marketing by the National Medical Products Administration (NMPA) in June 2021, Yi Kai Da has successfully been used to treat more than 700 lymphoma patients


Regarding Shanghai’s business environment, Guo Guangchang said, “Shanghai is the most important gateway for China’s opening-up, and the leading city for China’s economic development. Shanghai’s business environment is one of the best in the world and in China. The Shanghai Municipal People’s Government has demonstrated foresight, sound policies, and strong resolve to support the investment and development of domestic and foreign capital. We have genuinely felt the Shanghai Municipal People’s Government’s commitment and actions to support enterprises and help address their challenges. I sincerely welcome more New York and American companies to come to Shanghai, to Yuyuan Garden, to the Bund Finance Center (BFC), to experience the beauty of Shanghai. More importantly, let’s invest and establish businesses in Shanghai and share the future!”


This promotion event was held at Fosun’s 28 Liberty in New York. 28 Liberty was formerly the headquarters of JPMorgan and was acquired by Fosun in 2013. After over a decade of operation, 28 Liberty has become an iconic building in Manhattan, New York. It now houses a diverse array of offerings and consistently maintains an occupancy rate above 90%.



28 Liberty


Sing for Hope piano exhibition and performance was held at 28 Liberty


Fosun’s businesses in the U.S. covers health, happiness, wealth and other areas, with operations across 7 states including New York, New Jersey, and Massachusetts. Fosun’s main operating companies in the U.S. include Henlius USA, Fosun Pharma USA Inc, and fashion brand St. John, 3 asset management companies, as well as landmark projects such as 28 Liberty and Madison House in New York. Since entering the U.S. market in 2012, Fosun has maintained stable, compliance management and operations, and has organized various philanthropic and community events such as the Emerging Visionaries, Sing For Hope, and River to River, fully integrating into the local community and enhancing economic and cultural exchanges between China and the U.S.


share
x

抖音二维码

扫一扫